Labcorp Holdings Inc. (LON:0JSY)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 17.72B |
| Revenue (ttm) | 9.84B |
| Net Income (ttm) | 557.21M |
| Shares Out | n/a |
| EPS (ttm) | 6.62 |
| PE Ratio | 31.79 |
| Forward PE | 16.82 |
| Dividend | 2.21 (0.78%) |
| Ex-Dividend Date | Aug 28, 2025 |
| Volume | 23 |
| Average Volume | 138 |
| Open | 288.81 |
| Previous Close | 284.01 |
| Day's Range | 280.90 - 288.81 |
| 52-Week Range | 213.81 - 295.02 |
| Beta | 0.87 |
| RSI | 53.09 |
| Earnings Date | Oct 23, 2025 |
About Labcorp Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target... [Read more]
Financial Performance
In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.
Financial numbers in USD Financial StatementsNews
Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence
CHICAGO--(BUSINESS WIRE)--A streamlined digital experience improved lab order adherence, reduced no-shows, and enhanced operational efficiency at Providence.
Labcorp Holdings (LH): UBS Raises Price Target to $325 | LH Stock News
Labcorp Holdings (LH): UBS Raises Price Target to $325 | LH Stock News
Labcorp Holdings (LH) Receives Updated Price Target from Mizuho | LH Stock News
Labcorp Holdings (LH) Receives Updated Price Target from Mizuho | LH Stock News
If You Invested $100 In Labcorp Hldgs Stock 20 Years Ago, You Would Have This Much Today
Labcorp Hldgs (NYSE: LH) has outperformed the market over the past 20 years by 1.03% on an annualized basis producing an average annual return of 9.97%. Currently, Labcorp Hldgs has a market capitali...
Labcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock?
LH is poised for Q3 growth, with revenue and EPS estimates pointing higher as diagnostics and biopharma units deliver strong performances.
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C. , Oct. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has ...
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C. , Oct. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has d...
Labcorp Holdings (LH) Sees Analyst Rating Maintained and Price Target Raised by Evercore | LH ...
Labcorp Holdings (LH) Sees Analyst Rating Maintained and Price Target Raised by Evercore | LH Stock News
Barclays Maintains Equal-Weight Rating on Labcorp (LH), Raises Price Target | LH Stock News
Barclays Maintains Equal-Weight Rating on Labcorp (LH), Raises Price Target | LH Stock News
Labcorp partners with Roche to advance digital pathology and AI integration
Labcorp Collaborates With Roche To Implement VENTANA DP 600 And DP 200 Slide Scanners
(RTTNews) - Labcorp (LH) announced a collaboration with Roche to implement the company's FDA-cleared VENTANA DP 600 and DP 200 slide scanners. The investment enables pathologists to diagnose patients ...
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services BURLINGTON, N.C. , Sept. 30, 2025 /PRNewswir...
Labcorp to Announce Third Quarter Financial Results on October 28, 2025
BURLINGTON, N.C. , Sept. 25, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the thir...
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Reasons to Add Labcorp Stock to Your Portfolio Right Now
LH's biopharma lab growth and efficiency gains boost momentum, but currency and macro pressures weigh on its outlook.
Here's Why Labcorp Holdings (LH) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Labcorp Completes $225 Mln Acquisition Of BioReference Health's Oncology Testing Business
(RTTNews) - Labcorp (LH) and OPKO Health, Inc. announced the completion of Labcorp's acquisition of select BioReference Health assets focused on oncology and oncology-related clinical testing across t...
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
BURLINGTON, N.C. and MIAMI , Sept.
Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
BURLINGTON, N.C. , Aug. 27, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team ...
How Do Investors Really Feel About Labcorp Hldgs?
Labcorp Hldgs's (NYSE: LH) short percent of float has fallen 18.87% since its last report. The company recently reported that it has 2.75 million shares sold short , which is 4.3% of all regular shar...
Here's How Much $100 Invested In Labcorp Hldgs 20 Years Ago Would Be Worth Today
Labcorp Hldgs (NYSE: LH) has outperformed the market over the past 20 years by 1.16% on an annualized basis producing an average annual return of 9.85%. Currently, Labcorp Hldgs has a market capitali...
Labcorp launches FDA-cleared blood test for Alzheimer's disease
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C. , Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...
Is the Market Bullish or Bearish on Labcorp Hldgs?
Labcorp Hldgs's (NYSE: LH) short percent of float has fallen 3.99% since its last report. The company recently reported that it has 3.37 million shares sold short , which is 5.3% of all regular share...